1. Home
  2. TG vs ENTA Comparison

TG vs ENTA Comparison

Compare TG & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.67

Market Cap

353.3M

Sector

Industrials

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.66

Market Cap

371.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
ENTA
Founded
1988
1995
Country
United States
United States
Employees
N/A
120
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.3M
371.6M
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
TG
ENTA
Price
$7.67
$12.66
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
133.5K
207.6K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
29.93
EPS
0.17
N/A
Revenue
$800,821,000.00
$102,814,000.00
Revenue This Year
N/A
$7.76
Revenue Next Year
N/A
N/A
P/E Ratio
$45.53
N/A
Revenue Growth
8.29
16.48
52 Week Low
$6.25
$6.45
52 Week High
$10.53
$17.15

Technical Indicators

Market Signals
Indicator
TG
ENTA
Relative Strength Index (RSI) 48.93 42.37
Support Level $7.52 $11.92
Resistance Level $8.13 $13.97
Average True Range (ATR) 0.22 0.75
MACD 0.05 -0.15
Stochastic Oscillator 61.04 14.52

Price Performance

Historical Comparison
TG
ENTA

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: